Literature DB >> 15030537

Haemodialysis-related headache.

B Göksan1, F Karaali-Savrun, S Ertan, M Savrun.   

Abstract

Dialysis may induce severe headache as a result of a large amount of water and electrolyte shifts. It is important to recognize it because it can be a great problem to the patient and changing dialysis parameters or methods can prevent it. In this study we investigated the frequency and clinical characteristics of headaches occurring during haemodialysis (HD). Thirty female and 33 male patients with chronic renal failure on regular dialysis for at least 6 months in the HD unit of the Internal Medicine Department from 1996 to 2000 participated in the study. The dialysis solution contained acetate in 35 patients and bicarbonate in 28 patients. In all patients capillary dialysers and Cuprophan membranes were used and every session of dialysis lasted 4 h. All patients received the same questionnaire and they were visited randomly. Dialysis headache (DH) diagnosis was made according to the criteria of the International Headache Society. Patients with primary headache and under drug treatment during HD, which can cause headache, were excluded from the study. The frequency of DH, its relation to gender, age, dialysis technique and parameters and its features were investigated. DH was detected in 48% (n = 30) of the study group. Compared with dialysis solutions, no difference was found between patients with and without DH. The difference in the pre- and post-dialysis value of urea in patients with DH was statistically significant (P < 0.05). Patients with DH showed significantly higher mean systolic and diastolic blood pressure predialysis values in comparison with patients without DH (systolic, P < 0.001; diastolic, P < 0.01), whereas post-treatment values did not differ between the two groups. Fronto-temporal location, moderate severity, throbbing quality and short duration (<4 h) were the most prevalent features of DH in patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030537     DOI: 10.1111/j.1468-2982.2004.00668.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

Review 1.  Secondary headaches.

Authors:  Jack Gladstein
Journal:  Curr Pain Headache Rep       Date:  2006-10

2.  Headache during haemodialysis in a patient with shunt: a cause for concern?

Authors:  Padraig O'Sullivan; Jahangir Sajjad; Sahibzada Abrar; Charles Marks
Journal:  BMJ Case Rep       Date:  2015-03-27

3.  A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging.

Authors:  C L Chen; P H Lai; K J Chou; P T Lee; H M Chung; H C Fang
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 4.  When Headache Warns of Homeostatic Threat: the Metabolic Headaches.

Authors:  Parneet Grewal; Jonathan H Smith
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

Review 5.  Dialysis headache.

Authors:  Ana Luisa de Lima Antoniazzi; Alexandre Pinto Corrado
Journal:  Curr Pain Headache Rep       Date:  2007-08

Review 6.  Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease.

Authors:  Flaminia Coluzzi
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

7.  Headache Associated with Hemodialysis in Patients with End-Stage Renal Disease in India: A Common Yet Overlooked Comorbidity.

Authors:  Kishti T Chhaya; Saptak Mankad; Maulin K Shah; Mamta Patel; Devangi Desai; Soaham D Desai
Journal:  Ann Indian Acad Neurol       Date:  2021-09-14       Impact factor: 1.383

8.  Caffeine-withdrawal headache induced by hemodialysis.

Authors:  Petar M Nikić; Jasna Zidverc-Trajković; Branislav Andrić; Marija Milinković; Biljana Stojimirović
Journal:  J Headache Pain       Date:  2009-04-15       Impact factor: 7.277

Review 9.  Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review.

Authors:  Tonci Brkovic; Eliana Burilovic; Livia Puljak
Journal:  Patient Prefer Adherence       Date:  2016-06-23       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.